PND24 MEDICATION SIDE-EFFECTS AND ADHERENCE AMONG PATIENTS WITH MULTIPLE SCLEROSIS  by Farris, K et al.
A94 Abstracts
making (α > 0.7), some of the dimensions did not meet study cri-
teria for individual decision making. CONCLUSION: The Study
results do not support the use of any of the evaluated instru-
ments for individual decision making. Based on available psy-
chometric data, use of MSQ for group level decision making for
clinical trials is recommended.
NEUROLOGICAL DISORDERS—
Patient-Reported Outcomes
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OBJECTIVES: Examine medication side-effects and patients’
adherence to disease modifying medications. METHODS: A
two-wave Internet survey was conducted by Harris Interactive
among patients with multiple sclerosis in 2006, and 332 subjects
from the ﬁrst wave were analyzed (response rate 31%).
RESULTS: Respondents were generally satisﬁed with the effec-
tiveness of therapy, reporting 5 ± 1.0 (mean ± standard devia-
tion) with 6 the most satisﬁed. Over half of subjects (53.8%)
reported experiencing side effects. Frequent side effects were
head/muscle ache (36.8%), injection site reaction (31.9%),
fatigue (26.3%), fever (18.4%), pain (15.2%) and depression
(10.5%). The majority of side effects began <1 day after start-
ing therapy: 81.8% of head/muscle ache, 59.3% of site reaction
and 56.7% of fatigue began in <1 day. The majority of fever
(74.6%) lasted <1 day. The median duration of injection site
reaction was 3 days, head/muscle ache was 1 day, and fatigue
was 1 day. Over one-third (36.6%) of subjects reported forget-
ting (Horne scale) to take disease-modifying agents. CONCLU-
SION: Patients commonly reported side effects due to their
therapy with disease modifying agents. This study provides a
foundation for future research of determinants of MS patients’
adherence behavior.
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OBJECTIVES: Epilepsy represents the most prevalent and
serious neurological condition affecting children in their devel-
oping years. Epilepsy has a signiﬁcant impact on the health-
related quality of life (HRQoL) of children and their families. In
the last decade, signiﬁcant advances have been made to measure
HRQoL in children and adolescents with epilepsy; resulting in
the development of several HRQoL instruments. The aim of 
this study is to provide a comprehensive review of HRQoL
instruments used in children and adolescents with epilepsy.
METHODS: A literature review was conducted from January
1990–December 2006 using the following databases: Medline,
PsycINFO, and CINAHL using a combination of keywords like
“quality of life”, “epilepsy”, “seizures”, “children”, “adoles-
cents” and “instruments”. The instruments included in the
review were evaluated based on the number of items and
domains, scaling methods, and psychometric properties.
RESULTS: The literature search yielded 13 instruments includ-
ing 4 generic, 7 epilepsy-speciﬁc, and 2 domain-speciﬁc instru-
ments. The most widely used generic, epilepsy-speciﬁc, and
domain-speciﬁc instruments were Impact of Childhood Illness
Scale, Quality of Life in Childhood Epilepsy Questionnaire, and
Hague Restriction in Epilepsy Scale, respectively. The HRQoL
instruments varied widely in the age range (2–18 years), length
of the instruments (10–125 items), scaling methods, respondents
(child or the parent as proxy) and psychometric attributes such
as reliability, validity, and responsiveness. Most of the instru-
ments reviewed exhibited satisfactory internal consistency with
values ranging from 0.7 to 0.9. Also, most instruments reported
test-retest reliability and validity measures like construct, content
and criterion validity. CONCLUSION: The comprehensive
description of all the HRQoL instruments used in children and
adolescents with epilepsy will help researchers and clinicians
select the most appropriate instrument. It is hoped that complete
understanding of the impact of epilepsy on HRQoL can help in
the development of appropriate and effective interventions.
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OBJECTIVES: Restless Legs Syndrome (RLS) is a neurological
disorder that has been found to negatively impact a patient’s
quality of life (QoL). A number of QoL instruments speciﬁcally
designed for people with RLS have appeared in the literature.
The objectives of this study were to provide a comprehensive
review of all the QoL instruments and to evaluate the psycho-
metric properties and appropriateness of these instruments in
RLS. METHODS: A systematic literature search was conducted
by one author among literature published from January 1997
through December 2006 through Pubmed, Ovid, and ProQuest.
The search was completed using terms like quality of life, health
status, questionnaires, measures, scales, and restless leg syn-
drome. After the instruments were identiﬁed, a second search
was performed for studies reporting the psychometric properties
(reliability, validity, and responsiveness) of these instruments.
RESULTS: The search yielded one generic and two disease-spe-
ciﬁc QoL instruments: Short Form-36, Restless Legs Syndrome-
Quality of life questionnaire (RLS-QoL), and International RLS
Study Group (IRLSSG). Five studies were included in the review
that discussed the psychometric properties of these instruments.
These instruments were tested on patients above 18 years of age,
and with a diagnosis of RLS. SF-36 showed high internal con-
sistency (0.76–0.93) and was assessed for content, concurrent,
and criterion validity. The RLS-QoL was assessed for item con-
vergent validity (item-scale correlations of ≥0.4), internal con-
sistency (0.79–0.84), and responsiveness. IRLSSG showed a high
inter-examiner reliability (0.93–0.97), internal consistency of
0.87, and high criterion, concurrent, and discriminant validity.
CONCLUSION: This review conﬁrms a limited, yet emerging
use of QoL instruments in people with RLS. The review provides
information about the availability and quality of available instru-
ments in RLS, which can be of value to clinicians and other deci-
sion-makers in accurately diagnosing and treating RLS.
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OBJECTIVES: Both English and Chinese versions of the 8-item
Parkinson’s Disease Questionnaire (PDQ-8) have demonstrated
validity and reliability. However, the measurement equivalence
